GSK advisory: Advair warehouse theft
GlaxoSmithKline has announced that two lots of Advair Diskus medication were stolen earlier this month from the company's distribution facility near Richmond, Virginia.
GlaxoSmithKline (GSK) has announced that two lots of Advair Diskus medication were stolen from the company's distribution facility near Richmond, Va.
Because it has been removed from the legitimate supply chain, medication in the stolen cartons could pose a health risk, a statement from the company said.
The present storage conditions of the stolen product are unknown. Inhalers from these lots should not be dispensed, sold, or used, GSK said.
The lot numbers and quantities are: Lot 9ZP2255 - NDC 0173-0696-00, Advair Diskus 250/50, 60 Dose (14,400 inhalers) and Lot 9ZP3325 - NDC 0173-0697-00, Advair Diskus 500/50, 60 Dose (11,200 inhalers). These lots were awaiting distribution to retail pharmacies at the time of the theft.
"GSK has alerted its distributors and customers to the stolen lots," the company said.
Anyone who has information regarding this incident, has received suspicious or unsolicited offers for the Advair Diskus lots in question, or has received product from these lots is encouraged to contact the U.S. Food and Drug Administration (FDA) Office of Criminal Investigations at 1-800-551-3989. Patient or customer inquiries for the company should be directed to GSK's Customer Response Center at 1-888-825-5249.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
